Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations to transform global cancer care SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- At...

Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced its external digital slide quality assessments to support laboratories in achieving good-quality histology slides—essential for...

Check out this video on YouTube from Tribun Health. Jean-François Pomerol of BFM Business sits down to discuss Digital solutions for cancer diagnosis using AI. SOURCE:...

Stockholm, Sweden – Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, is thrilled to announce a collaboration with Roche, the world’s largest biotechnology company and the global leader in...

Ibex Survey discovers that more than 50% of Americans have received incorrect medical test results for themselves or a loved one; 60% would trust AI supporting diagnoses  BOSTON, Sept. 25, 2024 — Ibex Medical Analytics (Ibex), the...

Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit...